NCT03913234 2022-05-10Phase IB & II Study of Ribociclib With Trastuzumab Plus Letrozole in Postmenopausal HR+, HER2+ Advanced Breast Cancer PatientsYonsei UniversityPhase 1/2 Unknown95 enrolled
NCT04852081 2021-04-21Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.Blokhin's Russian Cancer Research CenterUnknown1,000 enrolled